17-492 - Efficacy and Safety of Eslicarbazepine Acetate as First Add-on to Levetiracetam or Lamotrigine Monotherapy or as Later Adjunctive Treatment for Subjects with Uncontrolled Partial-onset Seizures: A Multicenter, Open-label, Non-randomized Trial

Status: open

17-492 - Efficacy and Safety of Eslicarbazepine Acetate as First Add-on to Levetiracetam or Lamotrigine Monotherapy or as Later Adjunctive Treatment for Subjects with Uncontrolled Partial-onset Seizures: A Multicenter, Open-label, Non-randomized Trial

Treatment for Epilepsy

Contact Us Or call 251-665-8375

Description

A study of a drug to be used in addition with another drug to treat adults with Uncontrolled Partial-onset Seizures. IRB 17-492

Providers Associated With This Trial

Principle Investigator

This link will open in a new tab or window.